InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Kapadia Sandip, Chief Financial Officer. Officer active across 2 companies, notably Harmony Biosciences Holdings, Inc.. Aggregated, 10 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €428k. History available since 1 December 2022. The latest transaction was disclosed on 26 January 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
3,746 shares@ US$37.15250.0% of flowCommon StockSEC:0001677141-26-000004
3,746 shares@ US$37.1520.0067% mcap50.0% of flowCommon StockSEC:0001677141-26-000004:0
6,247 shares@ US$32.476516.8% of flowCommon StockSEC:0001415889-25-009936:0
15,000 shares0Common StockSEC:0001415889-25-009357:0
3,812 shares0Common StockSEC:0001415889-25-002158:0
25,000 shares@ US$29.0362.2% of flowCommon StockSEC:0001415889-25-001925:0
60,000 shares0Common StockSEC:0001415889-24-024357:0
15,000 shares0Common StockSEC:0001415889-24-009781:0
30,000 shares0Common StockSEC:0001415889-23-005668:0
5,000 shares@ US$1.1929100.0% of flowCommon StockSEC:0001209191-22-059462:0
10 of 10 declarations
About Kapadia Sandip
Sandip Kapadia is the Chief Financial Officer of Harmony Biosciences Holdings, Inc. He is responsible for the company's financial management, including financial planning, risk management, and financial reporting. His role is essential in ensuring the financial health of the organization and supporting its strategic growth. With extensive expertise in the financial field, he contributes to informed decision-making within the company.
